AMN Healthcare Services Inc (AMN)

Return on equity (ROE)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands -146,979 53,043 99,228 143,897 210,679 279,987 319,258 382,152 444,050 478,470 460,048 403,018 327,388 220,479 172,523 128,078 70,665 88,839 86,287 92,831
Total stockholders’ equity US$ in thousands 706,620 890,665 876,859 854,191 831,256 817,169 766,297 955,774 1,043,630 1,132,630 1,039,340 1,080,930 1,162,030 1,042,480 966,382 894,060 819,677 807,073 777,406 749,080
ROE -20.80% 5.96% 11.32% 16.85% 25.34% 34.26% 41.66% 39.98% 42.55% 42.24% 44.26% 37.28% 28.17% 21.15% 17.85% 14.33% 8.62% 11.01% 11.10% 12.39%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-146,979K ÷ $706,620K
= -20.80%

The Return on Equity (ROE) of AMN Healthcare Services Inc has shown significant volatility over the periods outlined in the data provided.

The ROE started at 12.39% in March 2020 before decreasing slightly to 11.10% in June 2020. It then remained relatively stable around the 11-12% range for the next few quarters, with a slight drop to 8.62% by December 2020.

From March 2021 onwards, there was a noticeable improvement in ROE, with successive increases in each quarter, reaching a peak of 44.26% in June 2022. This period indicated a strong performance in utilizing shareholder equity to generate profits.

However, from September 2022 onwards, there was a decline in ROE figures. The ROE dropped to 5.96% in September 2024 and turned negative at -20.80% by December 2024. This negative ROE suggests that the company's net income was insufficient to cover the equity in the business during that quarter, which may raise concerns about the company's financial health and profitability.

In conclusion, the company experienced fluctuations in its ROE over the period, with both positive and negative trends observed. Investors and stakeholders should closely monitor the company's financial performance to understand the factors influencing these changes in ROE and assess the company's ability to generate returns on shareholder equity sustainably.


Peer comparison

Dec 31, 2024